Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 4
2008 4
2009 5
2010 6
2011 3
2012 7
2013 1
2014 6
2015 8
2016 8
2017 2
2018 3
2019 2
2020 6
2021 16
2022 15
2023 5
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Special Issue: Nanobody.
Chames P, Rothbauer U. Chames P, et al. Among authors: rothbauer u. Antibodies (Basel). 2020 Mar 6;9(1):6. doi: 10.3390/antib9010006. Antibodies (Basel). 2020. PMID: 32155903 Free PMC article.
30 Jahre Nanobodies: Neues von kleinen Helfern mit großem Potenzial.
Wagner TR, Burgstaller S, Frecot DI, Lukowski R, Rothbauer U. Wagner TR, et al. Among authors: rothbauer u. Biospektrum (Heidelb). 2023;29(2):145-149. doi: 10.1007/s12268-023-1900-4. Epub 2023 Apr 13. Biospektrum (Heidelb). 2023. PMID: 37073321 Free PMC article. Review. German.
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer.
Rudalska R, Harbig J, Forster M, Woelffing P, Esposito A, Kudolo M, Botezatu A, Haller V, Janssen N, Holzmayer S, Nahidino P, Trompak O, Pantsar T, Kronenberger T, Yurttas C, Rist E, Weber ANR, Dahlke MH, Ott G, Koenigsrainer A, Rothbauer U, Maerklin M, Muerdter T, Schwab M, Singer S, Zender L, Laufer S, Dauch D. Rudalska R, et al. Among authors: rothbauer u. Nat Cancer. 2025 Feb;6(2):259-277. doi: 10.1038/s43018-024-00899-7. Epub 2025 Jan 16. Nat Cancer. 2025. PMID: 39820127 Free PMC article.
PET-based immunomapping of intratumoral CD4+ cells to monitor acquired resistance to checkpoint inhibitors.
Pezzana S, Blaess S, Traenkle B, Schaefer A, Ruoff L, Tako B, Castaneda Vega S, Kaiser PD, Wagner T, Gonzalez-Menendez I, Quintanilla-Martinez L, Rochwarger A, Schürch CM, Riel S, Schaller M, van Genugten EAJ, van der Hoorn IAE, Gorris MAJ, Steinvoort M, Peeters E, de Vries IJM, van den Heuvel MM, Aarntzen EHJG, Maurer A, Rothbauer U, Pichler BJ, Kneilling M, Sonanini D. Pezzana S, et al. Among authors: rothbauer u. Sci Adv. 2025 Jun 27;11(26):eadw1924. doi: 10.1126/sciadv.adw1924. Epub 2025 Jun 25. Sci Adv. 2025. PMID: 40561008 Free PMC article.
Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.
Frecot DI, Blaess S, Wagner TR, Kaiser PD, Traenkle B, Fandrich M, Jakobi M, Scholz AM, Nueske S, Schneiderhan-Marra N, Gouttefangeas C, Kneilling M, Pichler BJ, Sonanini D, Rothbauer U. Frecot DI, et al. Among authors: rothbauer u. Front Immunol. 2024 Oct 15;15:1480091. doi: 10.3389/fimmu.2024.1480091. eCollection 2024. Front Immunol. 2024. PMID: 39474429 Free PMC article.
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies.
Wagner TR, Ostertag E, Kaiser PD, Gramlich M, Ruetalo N, Junker D, Haering J, Traenkle B, Becker M, Dulovic A, Schweizer H, Nueske S, Scholz A, Zeck A, Schenke-Layland K, Nelde A, Strengert M, Walz JS, Zocher G, Stehle T, Schindler M, Schneiderhan-Marra N, Rothbauer U. Wagner TR, et al. Among authors: rothbauer u. EMBO Rep. 2021 May 5;22(5):e52325. doi: 10.15252/embr.202052325. Epub 2021 Apr 27. EMBO Rep. 2021. PMID: 33904225 Free PMC article.
105 results